ClinConnect ClinConnect Logo
Search / Trial NCT05816707

The Assessment of Curcuma Longa Potentials for Soft and Hard Tissue Healing in Fresh

Launched by RANIA FAROUK MOHAMED ABDULMAGUID · Apr 17, 2023

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of Curcuma longa, commonly known as curcumin, on healing after tooth extractions. Specifically, it aims to see if curcumin can help heal both soft and hard tissues in the mouth better than a standard treatment. The study will involve 30 patients who need to have two similar teeth extracted. One side will receive curcumin and a treatment called PRF (Platelet-Rich Fibrin), which is thought to promote healing, while the other side will be a control group that does not receive these treatments. Researchers will then evaluate how well the tissues heal after the procedure.

To be eligible for this trial, participants should be adults aged 18 to 50 who have severely decayed back teeth that need to be extracted and are generally in good health. They should not have any infections in their mouth or be allergic to curcumin. Additionally, individuals who smoke or are undergoing treatments like chemotherapy will not be able to participate. If you join the study, you can expect to have both sides of your mouth treated differently and to help researchers learn more about the healing process after dental extractions, which could lead to better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with bilateral badly decayed mandibular posterior tooth that need extraction.
  • 2. Patients free from any systemic disease 3. Patients who approved to be included in the trial and signed the informed consent.
  • 4. Patients with no signs or symptoms of acute periapical\\ periodontal infection.
  • 5. Adults aged between 18-50 years old.
  • Exclusion Criteria:
  • 1. Patients who are allergic to Curcumin 2. Smoker patient 3. Patients receiving chemotherapy or radiotherapy. 4. Patients who refused to be included in the trial.

About Rania Farouk Mohamed Abdulmaguid

Rania Farouk Mohamed Abdulmaguid is an esteemed clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative clinical studies. With a strong background in healthcare and a commitment to ethical research practices, she leads initiatives that prioritize participant safety and scientific integrity. Her expertise encompasses a wide range of therapeutic areas, fostering collaboration among multidisciplinary teams to ensure rigorous study design and execution. Rania's vision is to contribute to the development of effective treatments that address unmet medical needs, ultimately enhancing the quality of care within the healthcare community.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials